Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NCAN,Neurocan core protein,Inverse variance weighted,4,0.53 [0.39-0.73],6.51488574392825e-05,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD109,CD109 antigen,Inverse variance weighted,23,0.86 [0.78-0.94],0.000599562412961272,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,2.41 [1.44-4.02],0.000799935320587042,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ANPEP,Aminopeptidase N,Inverse variance weighted,11,1.21 [1.08-1.37],0.00143286948001029,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,KLK4,Kallikrein-4,Inverse variance weighted,8,1.24 [1.08-1.41],0.00191446695729581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,9,0.79 [0.67-0.93],0.00468918605789986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL10,Interleukin-10,Wald ratio,1,2.15 [1.26-3.68],0.00503253095465206,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,11,1.19 [1.05-1.34],0.00528249207227229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PCDHB15,Protocadherin beta-15,Inverse variance weighted,15,0.87 [0.79-0.96],0.00539986661737585,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.25 [0.09-0.69],0.00693457466170861,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,11,1.22 [1.05-1.41],0.00767609489684879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,2,3.26 [1.35-7.89],0.00871673658789899,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,11,0.89 [0.82-0.98],0.0121619413578438,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,17,0.86 [0.76-0.97],0.0150141586425952,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CREG1,Protein CREG1,Inverse variance weighted,2,0.72 [0.55-0.94],0.0156759250848167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,AREG,Amphiregulin,Inverse variance weighted,3,0.68 [0.5-0.93],0.0156925057598054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,15,1.2 [1.03-1.39],0.0195404499692624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,5,1.38 [1.05-1.81],0.0197888311298131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,0.34 [0.14-0.85],0.0205102243826784,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL17RB,Interleukin-17 receptor B,Inverse variance weighted,17,0.89 [0.81-0.98],0.022218937070195,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CTRB1,Chymotrypsinogen B,Inverse variance weighted,18,0.88 [0.78-0.99],0.0266340568489658,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,5,0.78 [0.63-0.97],0.0286662768556958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,11,1.15 [1.01-1.31],0.0303378627993949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,3,1.35 [1.03-1.78],0.0306586797794282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,THBS2,Thrombospondin-2,Inverse variance weighted,12,1.16 [1.01-1.32],0.0320788559768534,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD302,CD302 antigen,Inverse variance weighted,6,0.78 [0.62-0.98],0.0342727577405228,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GM2A,Ganglioside GM2 activator,Inverse variance weighted,16,1.1 [1.01-1.2],0.0359408279584591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,5,0.7 [0.5-0.98],0.0382500698174189,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,5,1.34 [1.02-1.76],0.038651599291023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,APCS,Serum amyloid P-component,Inverse variance weighted,4,1.29 [1.01-1.66],0.0404094671409463,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CEMIP2,Cell surface hyaluronidase,Inverse variance weighted,4,0.74 [0.56-0.99],0.0404751400787134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ACE,Angiotensin-converting enzyme,Inverse variance weighted,14,1.14 [1.01-1.29],0.0410057481533047,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,5,0.83 [0.7-0.99],0.0411767718123247,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,COLEC12,Collectin-12,Inverse variance weighted,7,0.74 [0.55-0.99],0.0420786569659125,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,12,1.26 [1.01-1.58],0.0430473219755172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,12,1.12 [1-1.26],0.045044211454673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,6,0.86 [0.74-1],0.0459450247819388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CCN3,CCN family member 3,Inverse variance weighted,13,0.83 [0.69-1],0.0463114198408085,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,4,0.61 [0.37-0.99],0.0473913953665259,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SIGLEC1,Sialoadhesin,Inverse variance weighted,11,0.88 [0.78-1],0.0474506546449696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,3,1.44 [1-2.06],0.0483192408230867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.29 [0.08-0.99],0.0490096926796605,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,5,1.51 [1-2.29],0.0497564303501828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,10,0.87 [0.76-1],0.0507500585399803,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,7,0.85 [0.71-1],0.0547071327568495,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,14,0.89 [0.79-1],0.0578964519810824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DSCAM,Down syndrome cell adhesion molecule,Inverse variance weighted,9,1.12 [1-1.25],0.0586460581036315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,BSG,Basigin,Wald ratio,1,1.46 [0.99-2.17],0.0593477773678385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.66 [0.43-1.02],0.0598983931077289,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LAYN,Layilin,Inverse variance weighted,12,0.85 [0.72-1.01],0.0599878108501996,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,12,0.89 [0.79-1.01],0.0607251574042988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.79 [0.61-1.01],0.0616217024210282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SLAMF8,SLAM family member 8,Inverse variance weighted,14,0.95 [0.89-1],0.0634996832038326,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,STC1,Stanniocalcin-1,Inverse variance weighted,2,2.11 [0.95-4.66],0.0658886476110372,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD244,Natural killer cell receptor 2B4,Inverse variance weighted,4,1.17 [0.99-1.38],0.0666451664184644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LGMN,Legumain,Inverse variance weighted,9,0.86 [0.73-1.01],0.0680896227055701,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CNTN1,Contactin-1,Inverse variance weighted,14,0.85 [0.71-1.01],0.0691989535697313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,4,1.24 [0.98-1.57],0.0734187941196044,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,4,1.25 [0.98-1.61],0.0734687852108667,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PALM,Paralemmin-1,Inverse variance weighted,5,1.28 [0.98-1.67],0.0737938908503189,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LPL,Lipoprotein lipase,Inverse variance weighted,8,1.12 [0.99-1.27],0.0743281993106047,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,BTN3A2,Butyrophilin subfamily 3 member A2,Wald ratio,1,0.87 [0.74-1.02],0.0763708189043536,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CST3,Cystatin-C,Inverse variance weighted,7,1.19 [0.98-1.44],0.0768144592032231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,9,1.17 [0.98-1.39],0.0783840546597123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.57 [0.3-1.07],0.0790799857065033,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CPVL,Probable serine carboxypeptidase CPVL,Inverse variance weighted,18,0.93 [0.85-1.01],0.0921612783934756,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ITGA5,Integrin alpha-5,Wald ratio,1,0.39 [0.13-1.18],0.0961748615419985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,XCL1,Lymphotactin,Inverse variance weighted,15,1.08 [0.99-1.19],0.0962405579756066,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,APOL1,Apolipoprotein L1,Wald ratio,1,1.2 [0.97-1.5],0.0975167342379986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,12,1.11 [0.98-1.25],0.101485545430269,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,AMBP,Protein AMBP,Inverse variance weighted,3,1.41 [0.93-2.11],0.102046193441003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,8,1.16 [0.97-1.39],0.105467388494539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD59,CD59 glycoprotein,Inverse variance weighted,5,0.83 [0.66-1.04],0.10584953934136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DKK3,Dickkopf-related protein 3,Inverse variance weighted,8,1.11 [0.98-1.27],0.106037865091545,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.6 [0.9-2.84],0.108526542087456,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DRAXIN,Draxin,Inverse variance weighted,8,0.86 [0.71-1.03],0.109465959148391,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,JAM2,Junctional adhesion molecule B,Wald ratio,1,0.37 [0.11-1.26],0.11121027987746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CHAD,Chondroadherin,Inverse variance weighted,2,0.54 [0.25-1.16],0.114832807690622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CLMP,CXADR-like membrane protein,Inverse variance weighted,9,0.86 [0.71-1.04],0.11586456974926,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,2,0.54 [0.25-1.16],0.11620057163567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LYPD8,Ly6/PLAUR domain-containing protein 8,Inverse variance weighted,6,0.86 [0.72-1.04],0.117095748357289,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,11,1.12 [0.97-1.3],0.118411976393787,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,UMOD,Uromodulin,Inverse variance weighted,18,1.07 [0.98-1.16],0.118941597382328,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD48,CD48 antigen,Inverse variance weighted,7,1.17 [0.96-1.43],0.119145778857098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SDC1,Syndecan-1,Inverse variance weighted,3,0.76 [0.54-1.07],0.119690178499632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SUSD4,Sushi domain-containing protein 4,Inverse variance weighted,5,0.82 [0.63-1.05],0.12032876639065,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,6,0.79 [0.59-1.06],0.120786695877502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,13,1.12 [0.97-1.29],0.122693015370457,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,10,1.1 [0.97-1.24],0.123201272564988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,10,0.86 [0.71-1.04],0.12410143279008,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.69 [0.44-1.11],0.124247921184255,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,14,1.11 [0.97-1.27],0.124692516475078,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PGA4,Pepsin A-4,Inverse variance weighted,2,2.69 [0.76-9.52],0.124694838629023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,7,0.88 [0.76-1.03],0.124851245189715,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,6,0.87 [0.72-1.04],0.127736909808988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,3,0.88 [0.74-1.04],0.128710793624274,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,15,1.1 [0.97-1.24],0.128763040203432,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,Wald ratio,1,0.37 [0.1-1.35],0.131843358054859,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,6,1.24 [0.94-1.64],0.132208875583593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,2,1.69 [0.85-3.37],0.133337159249767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FCN2,Ficolin-2,Inverse variance weighted,13,0.92 [0.81-1.03],0.134742771921337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD160,CD160 antigen,Inverse variance weighted,5,0.84 [0.67-1.06],0.135259623719728,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ITGAM,Integrin alpha-M,Inverse variance weighted,2,1.3 [0.92-1.82],0.135408647713185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,6,1.12 [0.97-1.29],0.136115744780918,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ERBB4,Receptor tyrosine-protein kinase erbB-4,Inverse variance weighted,5,0.83 [0.65-1.06],0.136164407301838,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD7,T-cell antigen CD7,Inverse variance weighted,3,0.91 [0.8-1.03],0.136909784128288,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,7,0.86 [0.7-1.05],0.138284864398467,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MUC2,Mucin-2,Inverse variance weighted,4,1.2 [0.94-1.53],0.13933859877874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,10,1.1 [0.97-1.24],0.140405571305136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,12,1.16 [0.95-1.4],0.141066712371022,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,23,1.05 [0.98-1.11],0.143556702503895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RNASE6,Ribonuclease K6,Inverse variance weighted,8,1.09 [0.97-1.21],0.145752790148052,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,8,1.14 [0.95-1.36],0.146667099634534,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,2,1.66 [0.84-3.3],0.147931051069064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,18,1.1 [0.97-1.25],0.14803563217878,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LAMB1,Laminin subunit beta-1,Inverse variance weighted,22,1.07 [0.98-1.18],0.1487017563129,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,7,0.88 [0.75-1.04],0.149145151619909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,3,0.88 [0.73-1.05],0.151103414294335,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,20,0.93 [0.84-1.03],0.155561238892823,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CR2,Complement receptor type 2,Inverse variance weighted,3,0.84 [0.65-1.07],0.156491587835578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,1.45 [0.87-2.42],0.157217386091934,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,14,1.13 [0.95-1.35],0.158098698685064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.18 [0.94-1.49],0.158741633764104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,9,1.16 [0.94-1.42],0.162047349037232,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SEMA3F,Semaphorin-3F,Inverse variance weighted,3,1.51 [0.85-2.71],0.162941930908397,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FOLR1,Folate receptor alpha,Inverse variance weighted,3,1.34 [0.89-2.01],0.164312841249698,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CPA2,Carboxypeptidase A2,Inverse variance weighted,11,0.91 [0.8-1.04],0.165725486666155,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,20,0.94 [0.85-1.03],0.169440671835,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PTPRC,Receptor-type tyrosine-protein phosphatase C,Inverse variance weighted,3,1.19 [0.93-1.53],0.170488095271174,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,5,1.22 [0.92-1.62],0.171780216429788,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,11,1.1 [0.96-1.25],0.171876851668267,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,4,0.87 [0.71-1.06],0.172087326371545,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LGALS3,Galectin-3,Inverse variance weighted,14,0.9 [0.78-1.05],0.172308594183517,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,12,1.13 [0.94-1.36],0.176881510853435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,4,0.67 [0.37-1.2],0.176954896537175,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,S100P,Protein S100-P,Wald ratio,1,1.97 [0.73-5.31],0.179120653407879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL19,Interleukin-19,Inverse variance weighted,7,0.88 [0.74-1.06],0.17915970584899,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NECTIN4,Nectin-4,Inverse variance weighted,6,1.13 [0.95-1.34],0.18045511493274,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DPP10,Inactive dipeptidyl peptidase 10,Inverse variance weighted,6,1.13 [0.94-1.36],0.181438404549341,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,AMY2B,Alpha-amylase 2B,Inverse variance weighted,12,0.93 [0.85-1.03],0.182108900213977,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,Inverse variance weighted,4,0.86 [0.68-1.08],0.186001694804654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,3,0.78 [0.53-1.13],0.186386809164644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IDI2,Isopentenyl-diphosphate delta-isomerase 2,Inverse variance weighted,8,1.1 [0.96-1.26],0.186436445419915,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,12,0.89 [0.74-1.06],0.18699401821257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,6,0.89 [0.74-1.06],0.187305285082435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SNCG,Gamma-synuclein,Inverse variance weighted,13,0.93 [0.84-1.03],0.187892660857442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SLAMF7,SLAM family member 7,Inverse variance weighted,12,0.92 [0.82-1.04],0.18966402510093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SPARCL1,SPARC-like protein 1,Inverse variance weighted,15,0.93 [0.83-1.04],0.189850758177502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD83,CD83 antigen,Inverse variance weighted,5,1.2 [0.91-1.57],0.191394366334712,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.25 [0.89-1.76],0.193411828150678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,4,0.88 [0.73-1.07],0.195137931273242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GALNT7,N-acetylgalactosaminyltransferase 7,Wald ratio,1,1.71 [0.76-3.84],0.19520726535313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,1.38 [0.85-2.25],0.196685572876851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.12 [0.94-1.34],0.198186466358975,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,0.73 [0.45-1.18],0.198446718347182,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,2,0.68 [0.38-1.23],0.198825582843162,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,8,0.89 [0.75-1.06],0.199519219276775,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FBLN2,Fibulin-2,Inverse variance weighted,3,0.86 [0.69-1.08],0.199913801618378,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,8,1.06 [0.97-1.16],0.200103821430817,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,AMY2A,Pancreatic alpha-amylase,Inverse variance weighted,11,0.94 [0.84-1.04],0.200160709618608,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,4,1.25 [0.89-1.74],0.201703156174653,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.73 [0.46-1.18],0.20247503975757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,8,0.76 [0.49-1.17],0.2046124371895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,3,1.47 [0.81-2.68],0.205036789112686,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,Inverse variance weighted,30,0.96 [0.9-1.02],0.205693533255932,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,2,0.73 [0.45-1.19],0.205934363466659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,16,0.92 [0.82-1.05],0.209796491150684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,5,1.1 [0.95-1.28],0.211265351248244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL32,Interleukin-32,Inverse variance weighted,6,1.13 [0.93-1.38],0.218245876499657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,14,1.08 [0.95-1.23],0.218356610356992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD79B,B-cell antigen receptor complex-associated protein beta chain,Wald ratio,1,0.81 [0.57-1.14],0.218773798720528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,3,1.43 [0.81-2.53],0.219371788064362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TCN2,Transcobalamin-2,Inverse variance weighted,18,0.93 [0.84-1.04],0.219844886263298,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CDH15,Cadherin-15,Inverse variance weighted,7,1.12 [0.93-1.34],0.223713994524436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TEK,Angiopoietin-1 receptor,Inverse variance weighted,13,0.92 [0.81-1.05],0.226908027775685,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,EFNA1,Ephrin-A1,Inverse variance weighted,8,1.13 [0.93-1.37],0.230432944298159,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ELN,Elastin,Wald ratio,1,0.67 [0.35-1.29],0.232264178130565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,4,0.71 [0.41-1.24],0.233230003527957,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,0.48 [0.15-1.6],0.235634661219615,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,6,1.12 [0.93-1.36],0.238268868328815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,0.92 [0.81-1.06],0.244283406006069,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PRTG,Protogenin,Inverse variance weighted,7,0.91 [0.79-1.06],0.244541372842163,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,KLB,Beta-klotho,Inverse variance weighted,21,0.93 [0.83-1.05],0.245023494872043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,1.1 [0.93-1.31],0.246483917042803,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.18 [0.89-1.57],0.246529057441648,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PRND,Prion-like protein doppel,Inverse variance weighted,8,0.91 [0.78-1.07],0.246587069269141,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CA3,Carbonic anhydrase 3,Inverse variance weighted,4,1.2 [0.88-1.64],0.246949713933978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GUCA2A,Guanylin,Inverse variance weighted,4,1.16 [0.9-1.48],0.248841404007847,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CTSL,Cathepsin L1,Wald ratio,1,1.97 [0.62-6.28],0.2522654895491,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NRP1,Neuropilin-1,Inverse variance weighted,8,1.11 [0.93-1.33],0.254521832596275,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,4,1.47 [0.76-2.85],0.254976713051656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MEP1B,Meprin A subunit beta,Inverse variance weighted,21,0.96 [0.9-1.03],0.267183054337425,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,THBD,Thrombomodulin,Inverse variance weighted,5,1.2 [0.87-1.67],0.26722649558528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,0.82 [0.58-1.16],0.267563370083194,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MDK,Midkine,Inverse variance weighted,3,1.41 [0.75-2.65],0.279381819642535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,OLFM4,Olfactomedin-4,Inverse variance weighted,19,0.94 [0.85-1.05],0.27975285855405,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PRSS8,Prostasin,Inverse variance weighted,4,1.46 [0.73-2.91],0.280002198838873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD58,Lymphocyte function-associated antigen 3,Wald ratio,1,0.56 [0.19-1.62],0.281979806830204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TTR,Transthyretin,Inverse variance weighted,2,1.27 [0.82-1.94],0.28209440093603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,0.89 [0.72-1.1],0.282470737263966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,6,0.85 [0.64-1.14],0.283492168779361,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,6,1.11 [0.92-1.34],0.285063262701463,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LEPR,Leptin receptor,Inverse variance weighted,5,1.14 [0.9-1.44],0.285934251580735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DSC2,Desmocollin-2,Inverse variance weighted,4,0.89 [0.73-1.1],0.286406737996528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TFF2,Trefoil factor 2,Inverse variance weighted,3,0.82 [0.57-1.18],0.287272733155393,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,13,0.94 [0.84-1.05],0.28776970673745,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,10,0.92 [0.8-1.07],0.287852113657426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NECTIN2,Nectin-2,Inverse variance weighted,3,0.86 [0.65-1.14],0.289790373150049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GDF15,Growth/differentiation factor 15,Inverse variance weighted,10,0.9 [0.74-1.1],0.294957323535912,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,KLK11,Kallikrein-11,Inverse variance weighted,2,1.07 [0.94-1.21],0.295287057885828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.44 [0.73-2.85],0.295442329867084,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.61 [0.23-1.56],0.300129229191223,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.75 [0.44-1.29],0.301314331956008,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,3,1.17 [0.87-1.58],0.305655446087579,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,1.18 [0.86-1.6],0.308016133439692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,7,0.83 [0.59-1.19],0.309631628711397,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,5,1.2 [0.85-1.7],0.309772224525696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,F3,Tissue factor,Inverse variance weighted,7,1.12 [0.9-1.4],0.311503255985737,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CCN4,CCN family member 4,Inverse variance weighted,14,0.93 [0.8-1.07],0.311568191674191,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,12,0.92 [0.79-1.08],0.312991153669583,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MSTN,Growth/differentiation factor 8,Wald ratio,1,1.78 [0.58-5.45],0.315035123089022,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FAM3D,Protein FAM3D,Inverse variance weighted,8,1.3 [0.78-2.16],0.315297582613941,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LGALS9,Galectin-9,Inverse variance weighted,12,0.9 [0.73-1.11],0.317901451404556,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Wald ratio,1,1.38 [0.73-2.62],0.319297859692752,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CPM,Carboxypeptidase M,Inverse variance weighted,3,1.2 [0.84-1.71],0.320186369328858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,BCAN,Brevican core protein,Wald ratio,1,1.66 [0.61-4.48],0.320452143792729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.88 [0.69-1.13],0.320457808665874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,HYAL1,Hyaluronidase-1,Inverse variance weighted,4,1.21 [0.83-1.76],0.323284050992198,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,8,1.05 [0.95-1.16],0.328594213018777,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,11,0.94 [0.84-1.06],0.333864626592917,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD300A,CMRF35-like molecule 8,Inverse variance weighted,3,1.17 [0.85-1.6],0.336317507705511,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ROBO2,Roundabout homolog 2,Inverse variance weighted,3,1.39 [0.71-2.71],0.338421479094392,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LGALS1,Galectin-1,Inverse variance weighted,4,1.1 [0.91-1.33],0.340429212160102,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PLIN3,Perilipin-3,Wald ratio,1,1.53 [0.63-3.69],0.3432688714974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,4,0.92 [0.76-1.1],0.344352555555351,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NCAM1,Neural cell adhesion molecule 1,Inverse variance weighted,14,1.06 [0.94-1.18],0.350595387031663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CNTN2,Contactin-2,Inverse variance weighted,12,0.96 [0.87-1.05],0.351172240713841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PCDH12,Protocadherin-12,Inverse variance weighted,5,1.08 [0.92-1.27],0.351986629265273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SPP1,Osteopontin,Inverse variance weighted,7,1.2 [0.82-1.76],0.352396653044295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,AFM,Afamin,Inverse variance weighted,3,1.3 [0.75-2.27],0.355652458248673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CTSD,Cathepsin D,Inverse variance weighted,7,0.93 [0.8-1.08],0.356740467420662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LCN15,Lipocalin-15,Inverse variance weighted,6,1.07 [0.93-1.24],0.35766877605628,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CTBS,Di-N-acetylchitobiase,Inverse variance weighted,7,0.94 [0.84-1.07],0.358076270531034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SPON2,Spondin-2,Inverse variance weighted,4,1.12 [0.88-1.41],0.358646541436653,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FCRLB,Fc receptor-like B,Inverse variance weighted,16,0.96 [0.88-1.05],0.361621497676272,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,3,0.85 [0.6-1.21],0.361956476122118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD276,CD276 antigen,Inverse variance weighted,14,0.95 [0.85-1.06],0.363447118733368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,AOC3,Membrane primary amine oxidase,Inverse variance weighted,13,0.95 [0.85-1.06],0.363703007556747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD46,Membrane cofactor protein,Wald ratio,1,1.33 [0.72-2.48],0.364026953490851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NPTX1,Neuronal pentraxin-1,Inverse variance weighted,8,0.95 [0.84-1.07],0.367315913593992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,4,1.09 [0.91-1.3],0.367835249307211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MMP3,Stromelysin-1,Inverse variance weighted,16,0.94 [0.83-1.07],0.367989085110966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,9,0.91 [0.74-1.12],0.368570334794225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RSPO3,R-spondin-3,Inverse variance weighted,3,0.87 [0.64-1.18],0.369351417805018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,STC2,Stanniocalcin-2,Inverse variance weighted,2,1.48 [0.62-3.5],0.373870869603704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,13,0.94 [0.83-1.07],0.375740941290432,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,6,0.95 [0.85-1.06],0.377804836736827,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,VWC2,Brorin,Inverse variance weighted,15,1.06 [0.93-1.21],0.378169224125969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,3,1.23 [0.78-1.94],0.37864372069542,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NUCB2,Nucleobindin-2,Inverse variance weighted,13,0.92 [0.76-1.11],0.381775766930061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,4,1.15 [0.84-1.56],0.382590292092174,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,7,1.07 [0.92-1.25],0.38418483647911,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,13,0.94 [0.81-1.08],0.387400555194059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CDH3,Cadherin-3,Wald ratio,1,0.73 [0.35-1.5],0.38915140120709,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,3,1.07 [0.91-1.26],0.395627708644729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,8,0.88 [0.65-1.19],0.399826513048946,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,3,0.82 [0.51-1.31],0.401800765987072,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,10,0.95 [0.83-1.08],0.401971327628513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,BGLAP,Osteocalcin,Wald ratio,1,1.19 [0.79-1.79],0.40312399650199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,14,1.08 [0.9-1.3],0.403258836385567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,2,1.14 [0.84-1.56],0.403370609457458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,18,1.06 [0.92-1.23],0.409078511796074,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CLPS,Colipase,Inverse variance weighted,22,1.04 [0.94-1.15],0.411122367882357,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,2,0.81 [0.5-1.33],0.412507223930423,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,5,1.12 [0.86-1.45],0.412668271857295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,POSTN,Periostin,Inverse variance weighted,6,1.17 [0.8-1.72],0.414719253468659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FGF23,Fibroblast growth factor 23,Wald ratio,1,0.8 [0.47-1.36],0.41537335550068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,12,0.95 [0.84-1.07],0.415850449292618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CTSS,Cathepsin S,Inverse variance weighted,14,1.05 [0.93-1.18],0.416577717887209,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,THBS4,Thrombospondin-4,Inverse variance weighted,7,1.09 [0.88-1.34],0.419619660200665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,18,1.06 [0.92-1.21],0.419893944751953,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,12,0.96 [0.86-1.06],0.419901318526315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,6,0.93 [0.76-1.12],0.422319128540225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,REN,Renin,Inverse variance weighted,3,1.28 [0.69-2.39],0.428341623945097,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,4,0.92 [0.75-1.13],0.437827127262137,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CX3CL1,Fractalkine,Inverse variance weighted,5,1.24 [0.72-2.11],0.438604992444661,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,3,1.06 [0.92-1.21],0.442346932804223,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,0.66 [0.23-1.91],0.443722949490281,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,13,0.95 [0.84-1.08],0.447519827827376,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ANXA5,Annexin A5,Wald ratio,1,1.22 [0.73-2.04],0.448372323970746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CTSZ,Cathepsin Z,Wald ratio,1,0.58 [0.14-2.37],0.45091458934912,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.93 [0.78-1.12],0.451236404096967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Wald ratio,1,1.67 [0.44-6.29],0.451797522089372,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CPA1,Carboxypeptidase A1,Inverse variance weighted,2,0.89 [0.65-1.21],0.451984871207536,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CCL15,C-C motif chemokine 15,Inverse variance weighted,11,0.97 [0.88-1.06],0.455099725582003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,10,0.95 [0.82-1.09],0.45627102220883,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RBP2,Retinol-binding protein 2,Wald ratio,1,0.73 [0.32-1.67],0.456489604564914,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Wald ratio,1,1.22 [0.72-2.09],0.456808998930317,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CHGA,Chromogranin-A,Inverse variance weighted,3,1.11 [0.84-1.46],0.458874151972736,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,2,1.09 [0.87-1.37],0.464544508948567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.95 [0.81-1.1],0.466426009197236,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.83 [0.5-1.37],0.468433099880577,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.94 [0.78-1.12],0.469581742953237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,7,0.94 [0.81-1.1],0.470561097404579,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,2,0.89 [0.64-1.23],0.470636917165962,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RETN,Resistin,Inverse variance weighted,4,1.07 [0.89-1.27],0.470863093208086,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,6,0.94 [0.78-1.12],0.472636589106928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,6,0.93 [0.77-1.13],0.475323491113574,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,15,0.95 [0.82-1.1],0.477104204134141,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.83 [0.5-1.38],0.477295515157245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,HEG1,Protein HEG homolog 1,Inverse variance weighted,3,0.86 [0.58-1.29],0.47748588788166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.2 [0.73-1.97],0.479248764676528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,18,1.03 [0.95-1.13],0.479874579768759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CSTB,Cystatin-B,Inverse variance weighted,23,1.03 [0.95-1.12],0.480457544387957,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.38 [0.57-3.34],0.480588775544436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,2,0.87 [0.59-1.28],0.482036653381631,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ESAM,Endothelial cell-selective adhesion molecule,Wald ratio,1,0.87 [0.58-1.29],0.482766634720489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,2,0.85 [0.54-1.34],0.484484719206541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,21,0.97 [0.89-1.06],0.484542550038284,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,15,1.04 [0.93-1.17],0.48903514015543,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MMP12,Macrophage metalloelastase,Inverse variance weighted,15,1.04 [0.93-1.17],0.490428442795609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",Inverse variance weighted,3,1.08 [0.87-1.34],0.491156312020626,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,Inverse variance weighted,28,1.02 [0.96-1.08],0.491319208685049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,8,0.95 [0.81-1.1],0.492953603611103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,C7,Complement component C7,Inverse variance weighted,15,0.96 [0.87-1.07],0.497117632303997,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FAM3B,Protein FAM3B,Inverse variance weighted,8,1.05 [0.91-1.21],0.497761784818854,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,18,0.96 [0.87-1.07],0.499204609339123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NFASC,Neurofascin,Inverse variance weighted,14,1.04 [0.93-1.16],0.500516649337494,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,5,0.91 [0.69-1.2],0.504226055872929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DSG2,Desmoglein-2,Inverse variance weighted,6,0.93 [0.74-1.16],0.504580762760773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CDHR5,Cadherin-related family member 5,Inverse variance weighted,15,1.03 [0.94-1.13],0.505318885475147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CTSE,Cathepsin E,Inverse variance weighted,7,1.05 [0.91-1.2],0.508075567183858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADM,Pro-adrenomedullin,Wald ratio,1,1.2 [0.69-2.08],0.512706320017392,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,3,1.07 [0.87-1.32],0.513860037657299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,15,0.96 [0.84-1.09],0.516318264836882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,VNN2,Vascular non-inflammatory molecule 2,Inverse variance weighted,15,1.05 [0.9-1.22],0.516867416744525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ANXA10,Annexin A10,Wald ratio,1,1.43 [0.48-4.3],0.518936682544347,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,8,0.93 [0.75-1.16],0.520450653328133,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SEZ6L,Seizure 6-like protein,Inverse variance weighted,7,0.9 [0.65-1.24],0.521075938213377,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,4,0.86 [0.54-1.36],0.521175519299609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TFF1,Trefoil factor 1,Inverse variance weighted,7,1.06 [0.88-1.28],0.521621270279641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,12,1.05 [0.91-1.22],0.52307816095108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PRRT3,Proline-rich transmembrane protein 3,Wald ratio,1,1.16 [0.73-1.83],0.5236600550099,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FCRL5,Fc receptor-like protein 5,Inverse variance weighted,11,0.96 [0.85-1.08],0.524360838229727,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ASPN,Asporin,Inverse variance weighted,8,1.07 [0.87-1.3],0.526996491477908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.86 [0.55-1.36],0.527289723786296,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.14 [0.76-1.7],0.532168751209146,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PALM2,Paralemmin-2,Inverse variance weighted,8,1.07 [0.87-1.32],0.532260712461667,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,7,0.95 [0.81-1.12],0.535089526320821,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CDH5,Cadherin-5,Inverse variance weighted,3,1.09 [0.84-1.41],0.5371580604489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CDH6,Cadherin-6,Inverse variance weighted,16,1.03 [0.94-1.13],0.540228564112246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,10,0.96 [0.85-1.09],0.541878134815549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CDH2,Cadherin-2,Inverse variance weighted,3,0.88 [0.6-1.31],0.543933507088894,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ITGB2,Integrin beta-2,Inverse variance weighted,3,0.87 [0.55-1.37],0.544353868204904,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,0.88 [0.59-1.33],0.545628912665822,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADA,Adenosine deaminase,Inverse variance weighted,15,0.97 [0.88-1.07],0.547273416235558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GRN,Progranulin,Inverse variance weighted,4,0.89 [0.6-1.31],0.548741384127881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,3,0.9 [0.65-1.26],0.552826814166305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,7,0.94 [0.76-1.16],0.554901174971153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,32,1.02 [0.95-1.09],0.556605879839584,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,BOC,Brother of CDO,Inverse variance weighted,5,1.1 [0.81-1.49],0.557727558420889,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SELE,E-selectin,Inverse variance weighted,2,1.33 [0.51-3.47],0.56015519741275,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,7,1.04 [0.91-1.19],0.563427663266537,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,4,1.12 [0.76-1.64],0.563609354295342,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,3,1.07 [0.84-1.37],0.566787724458559,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.83 [0.43-1.58],0.567152515442842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PCDH1,Protocadherin-1,Wald ratio,1,1.22 [0.62-2.4],0.568184085670161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CELA2A,Chymotrypsin-like elastase family member 2A,Inverse variance weighted,2,0.88 [0.58-1.35],0.568706107819542,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.17 [0.67-2.05],0.574356376353967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PVR,Poliovirus receptor,Inverse variance weighted,13,1.03 [0.93-1.14],0.576877908583069,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PENK,Proenkephalin-A,Inverse variance weighted,11,1.04 [0.9-1.21],0.577094123858317,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TFF3,Trefoil factor 3,Inverse variance weighted,3,0.88 [0.56-1.39],0.578692320561559,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL5RA,Interleukin-5 receptor subunit alpha,Inverse variance weighted,13,0.97 [0.86-1.09],0.578778156908607,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,11,1.04 [0.91-1.19],0.579504653789226,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,2,1.13 [0.73-1.73],0.579972302689661,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,15,1.02 [0.95-1.1],0.586212751241916,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PDCD1,Programmed cell death protein 1,Inverse variance weighted,2,1.11 [0.75-1.64],0.587508041860886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,4,1.11 [0.75-1.64],0.589247188021714,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SCG2,Secretogranin-2,Wald ratio,1,1.41 [0.41-4.85],0.589971141157096,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MFGE8,Lactadherin,Inverse variance weighted,7,1.09 [0.8-1.47],0.590030383356043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.95 [0.8-1.14],0.590239246898566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,12,0.97 [0.88-1.07],0.590986078828866,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD55,Complement decay-accelerating factor,Inverse variance weighted,10,1.04 [0.91-1.19],0.594716561086876,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PRSS27,Serine protease 27,Inverse variance weighted,5,0.89 [0.58-1.37],0.595993221245959,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,2,0.9 [0.61-1.33],0.599334722392886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,AMIGO2,Amphoterin-induced protein 2,Inverse variance weighted,8,0.94 [0.73-1.2],0.599672807760558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,2,1.14 [0.7-1.86],0.599701020464696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LPO,Lactoperoxidase,Inverse variance weighted,2,0.95 [0.77-1.16],0.599704382582657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PRG2,Bone marrow proteoglycan,Wald ratio,1,0.86 [0.49-1.51],0.600827927323462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MVK,Mevalonate kinase,Wald ratio,1,0.83 [0.41-1.67],0.601052504630468,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,AFP,Alpha-fetoprotein,Inverse variance weighted,5,0.91 [0.66-1.28],0.601689371869689,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.85 [0.45-1.59],0.605635690024077,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,4,0.89 [0.58-1.37],0.606415012162811,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,3,0.95 [0.79-1.15],0.608530605846038,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,6,1.03 [0.93-1.13],0.611378894915932,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PTPRM,Receptor-type tyrosine-protein phosphatase mu,Inverse variance weighted,2,1.43 [0.35-5.77],0.614960485361549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,8,0.94 [0.74-1.2],0.616587734132542,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DTNB,Dystrobrevin beta,Wald ratio,1,1.38 [0.38-4.99],0.618635828399961,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,24,0.98 [0.89-1.07],0.621429000513879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,21,1.02 [0.94-1.12],0.624213946552599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,1.16 [0.64-2.09],0.624976650070758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,7,0.87 [0.5-1.52],0.630984350157805,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CALB1,Calbindin,Wald ratio,1,1.3 [0.45-3.75],0.631058989545955,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,3,1.12 [0.71-1.75],0.634337555339116,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,9,0.95 [0.76-1.18],0.634945818007489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MMP7,Matrilysin,Inverse variance weighted,9,0.95 [0.78-1.17],0.635206638729636,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,3,1.09 [0.76-1.58],0.635719832257537,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SEMA7A,Semaphorin-7A,Inverse variance weighted,4,0.86 [0.45-1.62],0.636469725680963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,4,0.95 [0.77-1.17],0.638843086798352,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,5,1.03 [0.91-1.16],0.638994114559434,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SPON1,Spondin-1,Inverse variance weighted,10,0.94 [0.74-1.2],0.642567030799302,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,13,0.97 [0.87-1.09],0.643493212581629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,2,1.19 [0.57-2.49],0.64666795744195,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,BCAM,Basal cell adhesion molecule,Inverse variance weighted,7,1.04 [0.87-1.24],0.647409540581339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MCAM,Cell surface glycoprotein MUC18,Wald ratio,1,0.92 [0.63-1.33],0.649939481116633,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,6,0.89 [0.54-1.47],0.650403805455375,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,21,1.03 [0.9-1.19],0.653343307509522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,13,1.03 [0.89-1.2],0.654208437961705,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,APOA2,Apolipoprotein A-II,Wald ratio,1,0.83 [0.36-1.91],0.657265291044918,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,Inverse variance weighted,7,0.94 [0.71-1.24],0.660001795155874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CCL25,C-C motif chemokine 25,Inverse variance weighted,20,0.98 [0.87-1.09],0.661343169838588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,WNT9A,Protein Wnt-9a,Inverse variance weighted,2,1.26 [0.45-3.55],0.66346098238974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FOLR2,Folate receptor beta,Wald ratio,1,1.12 [0.67-1.87],0.664635260784707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NRP2,Neuropilin-2,Inverse variance weighted,10,0.95 [0.75-1.2],0.669079106566659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CPB1,Carboxypeptidase B,Wald ratio,1,0.9 [0.55-1.48],0.674124330190065,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,12,0.97 [0.85-1.11],0.674602626439303,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FGF5,Fibroblast growth factor 5,Inverse variance weighted,17,0.98 [0.88-1.09],0.675784324555478,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD300E,CMRF35-like molecule 2,Inverse variance weighted,7,0.97 [0.82-1.14],0.676059532391096,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PLA2G1B,Phospholipase A2,Wald ratio,1,1.23 [0.46-3.31],0.678688659913092,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MUC13,Mucin-13,Inverse variance weighted,9,0.96 [0.79-1.17],0.688032602421095,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CALCA,Calcitonin,Inverse variance weighted,3,1.27 [0.39-4.11],0.688227619057814,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,5,0.97 [0.84-1.12],0.690216162132374,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GHR,Growth hormone receptor,Inverse variance weighted,15,1.04 [0.87-1.24],0.69042992835525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SFRP4,Secreted frizzled-related protein 4,Inverse variance weighted,3,1.05 [0.82-1.35],0.691909988759172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.96 [0.79-1.17],0.696446634785295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,6,1.03 [0.89-1.19],0.701889289524423,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RBP7,Retinoid-binding protein 7,Inverse variance weighted,4,1.09 [0.71-1.66],0.703483855987552,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ENG,Endoglin,Inverse variance weighted,6,0.93 [0.62-1.38],0.70369081218116,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PI16,Peptidase inhibitor 16,Inverse variance weighted,8,0.94 [0.7-1.27],0.704356716737293,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,3,0.92 [0.6-1.42],0.705225524729399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.9 [0.5-1.59],0.706561280933315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.19 [0.48-2.92],0.707475879880199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RNASE4,Ribonuclease 4,Inverse variance weighted,8,0.96 [0.8-1.17],0.710864875665993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.09 [0.7-1.69],0.711862847219793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.92 [0.59-1.43],0.712206985032244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.91 [0.55-1.51],0.712302717360363,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,10,0.98 [0.87-1.1],0.719397115139685,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,8,1.05 [0.81-1.36],0.720907516936491,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD164,Sialomucin core protein 24,Inverse variance weighted,3,0.94 [0.67-1.32],0.7234839037178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,15,1.03 [0.88-1.2],0.724124896417422,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SHISA5,Protein shisa-5,Inverse variance weighted,3,0.92 [0.59-1.45],0.724713048837994,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,19,0.99 [0.91-1.07],0.724797194129012,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.05 [0.8-1.37],0.725680221122884,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,4,0.96 [0.74-1.23],0.72621522765461,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.93 [0.64-1.37],0.72655707205281,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,AHNAK2,Protein AHNAK2,Inverse variance weighted,3,0.96 [0.75-1.22],0.72709117029548,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MMP10,Stromelysin-2,Inverse variance weighted,10,0.97 [0.81-1.16],0.727927840930303,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,7,1.05 [0.8-1.36],0.730571337225844,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TMPRSS15,Enteropeptidase,Inverse variance weighted,3,1.09 [0.66-1.79],0.736263011923279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,REG1B,Lithostathine-1-beta,Inverse variance weighted,10,0.97 [0.82-1.15],0.736402038053281,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,5,1.02 [0.89-1.18],0.736993703860392,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,7,1.06 [0.74-1.52],0.737409412957538,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.04 [0.82-1.31],0.740786429987272,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,1.22 [0.37-4.07],0.741303678579157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SPOCK1,Testican-1,Inverse variance weighted,3,0.95 [0.67-1.32],0.744049987350879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.82 [0.25-2.7],0.745115089177603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,VASN,Vasorin,Inverse variance weighted,8,1.02 [0.91-1.15],0.748769904503769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CLEC3B,Tetranectin,Inverse variance weighted,6,1.04 [0.83-1.3],0.752626641827739,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PADI2,Protein-arginine deiminase type-2,Wald ratio,1,0.93 [0.59-1.47],0.753667540363898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,3,1.1 [0.61-1.96],0.754821702447189,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CA4,Carbonic anhydrase 4,Inverse variance weighted,3,0.97 [0.82-1.15],0.758818432987066,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ITGB6,Integrin beta-6,Inverse variance weighted,8,0.98 [0.84-1.14],0.759696936708354,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,9,0.97 [0.8-1.17],0.760492514536885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CTSO,Cathepsin O,Inverse variance weighted,7,1.07 [0.71-1.61],0.761983274768776,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NAGK,N-acetyl-D-glucosamine kinase,Inverse variance weighted,2,0.96 [0.75-1.23],0.762963664702791,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PCDH7,Protocadherin-7,Inverse variance weighted,2,0.93 [0.57-1.5],0.763177349398896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CCL20,C-C motif chemokine 20,Wald ratio,1,1.09 [0.6-1.98],0.768324476907782,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,AGRN,Agrin,Inverse variance weighted,6,0.98 [0.83-1.15],0.769603596578744,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MILR1,Allergin-1,Inverse variance weighted,20,1.02 [0.92-1.12],0.770884267061837,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.87 [0.35-2.16],0.771942235163498,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.24 [0.29-5.25],0.773786657697455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ROBO1,Roundabout homolog 1,Inverse variance weighted,4,1.1 [0.58-2.07],0.774432916070829,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,3,1.1 [0.58-2.07],0.775544790953071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,EPO,Erythropoietin,Wald ratio,1,1.11 [0.54-2.29],0.776332979405034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,OGN,Mimecan,Inverse variance weighted,24,1.02 [0.91-1.13],0.779585076658644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MME,Neprilysin,Inverse variance weighted,3,0.9 [0.41-1.96],0.782152918281749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,3,0.97 [0.77-1.22],0.786431984254787,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,5,0.97 [0.8-1.19],0.787517080469309,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NTRK2,BDNF/NT-3 growth factors receptor,Inverse variance weighted,2,1.09 [0.58-2.07],0.78785421674178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RNASET2,Ribonuclease T2,Inverse variance weighted,9,0.98 [0.85-1.13],0.789899992681015,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,9,1.02 [0.88-1.18],0.790386727093151,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,13,0.98 [0.87-1.11],0.791468134487453,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,12,0.99 [0.88-1.1],0.793096583083991,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,15,1.02 [0.89-1.16],0.794551193554881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,6,0.98 [0.82-1.16],0.796438843659064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SLC39A14,Zinc transporter ZIP14,Wald ratio,1,1.08 [0.6-1.93],0.797503643076868,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PRELP,Prolargin,Inverse variance weighted,9,1.02 [0.88-1.17],0.803241555682424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD300C,CMRF35-like molecule 6,Wald ratio,1,1.05 [0.72-1.53],0.804649145180922,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PRSS2,Trypsin-2,Inverse variance weighted,3,0.93 [0.53-1.64],0.806277848032022,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CTRC,Chymotrypsin-C,Inverse variance weighted,10,1.02 [0.86-1.22],0.806987392406849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,Inverse variance weighted,11,1.01 [0.9-1.14],0.808660964498539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD27,CD27 antigen,Inverse variance weighted,8,0.97 [0.78-1.21],0.814139460263804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.02 [0.85-1.22],0.814740634967862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.1 [0.51-2.35],0.815133467682525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,10,1.02 [0.84-1.25],0.815360259460269,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,6,0.96 [0.64-1.42],0.82422262350879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,9,1.01 [0.91-1.13],0.8247846217408,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PSAP,Prosaposin,Inverse variance weighted,4,1.03 [0.81-1.3],0.82542394948597,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,4,0.96 [0.7-1.33],0.827826303552531,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.94 [0.52-1.7],0.829966929751031,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GSN,Gelsolin,Inverse variance weighted,3,0.95 [0.61-1.49],0.832235832724404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MXRA8,Matrix remodeling-associated protein 8,Wald ratio,1,1.11 [0.41-3],0.832681594816005,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.06 [0.63-1.79],0.833726954996224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CNTN4,Contactin-4,Inverse variance weighted,16,1.02 [0.87-1.19],0.838789360350416,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,20,1.01 [0.92-1.11],0.841668316426813,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,10,1.02 [0.81-1.29],0.844131310121028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ULBP2,UL16-binding protein 2,Inverse variance weighted,13,0.99 [0.87-1.12],0.844838093091017,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,EFNA4,Ephrin-A4,Wald ratio,1,0.9 [0.3-2.7],0.846406630962332,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,10,0.98 [0.83-1.17],0.848851198230796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RGMB,RGM domain family member B,Inverse variance weighted,6,1.03 [0.73-1.45],0.851335233238963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,6,0.98 [0.81-1.19],0.852207469473012,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,VAMP5,Vesicle-associated membrane protein 5,Inverse variance weighted,2,0.95 [0.52-1.71],0.852392682545257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,5,0.96 [0.59-1.54],0.855288920595256,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,6,0.97 [0.68-1.38],0.857244424819391,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PLXDC2,Plexin domain-containing protein 2,Inverse variance weighted,4,0.96 [0.6-1.53],0.857479561076958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,23,0.99 [0.92-1.07],0.859629285417537,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,7,0.98 [0.8-1.2],0.86333612260793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CA9,Carbonic anhydrase 9,Inverse variance weighted,2,0.97 [0.68-1.38],0.863623720678916,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.06 [0.55-2.05],0.864624119790082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ARHGEF5,Rho guanine nucleotide exchange factor 5,Inverse variance weighted,13,1.01 [0.9-1.14],0.864788433160983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CCN5,CCN family member 5,Inverse variance weighted,3,0.94 [0.43-2.04],0.867266915350549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,1.03 [0.75-1.4],0.867521781289937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LGALS4,Galectin-4,Inverse variance weighted,3,0.96 [0.63-1.47],0.867859465402607,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CELA3A,Chymotrypsin-like elastase family member 3A,Inverse variance weighted,6,1.02 [0.81-1.29],0.868733549376283,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,OCLN,Occludin,Wald ratio,1,0.97 [0.65-1.43],0.871397840041351,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PYY,Peptide YY,Inverse variance weighted,3,0.98 [0.74-1.29],0.872617889265228,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,4,0.98 [0.73-1.31],0.874746095829994,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ITGB7,Integrin beta-7,Wald ratio,1,1.07 [0.45-2.57],0.875717748377584,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,13,0.99 [0.91-1.08],0.877169021121969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,10,0.99 [0.84-1.16],0.879251842410331,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,8,1.01 [0.87-1.18],0.88010885105037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MANSC1,MANSC domain-containing protein 1,Wald ratio,1,1.09 [0.36-3.25],0.880833714801413,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MATN3,Matrilin-3,Inverse variance weighted,16,0.99 [0.9-1.1],0.881480647872216,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,12,1.01 [0.88-1.17],0.881948936676352,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,4,0.99 [0.81-1.2],0.885263554635497,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,2,1.13 [0.21-5.94],0.885671726946747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.01 [0.88-1.16],0.886882182506443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,22,0.99 [0.9-1.09],0.890540611234958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,8,0.99 [0.83-1.17],0.890619589842486,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,3,0.97 [0.65-1.46],0.894134242305853,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PGF,Placenta growth factor,Inverse variance weighted,2,0.94 [0.37-2.39],0.895121842226828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PKD1,Polycystin-1,Inverse variance weighted,5,1.03 [0.69-1.52],0.900011623635708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADA2,Adenosine deaminase 2,Inverse variance weighted,3,1.02 [0.77-1.35],0.900434080668242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,VCAN,Versican core protein,Inverse variance weighted,9,0.99 [0.85-1.15],0.901325378302657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,GPC1,Glypican-1,Inverse variance weighted,15,0.99 [0.83-1.18],0.902552844061951,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,3,0.97 [0.63-1.51],0.905287637372739,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CPQ,Carboxypeptidase Q,Inverse variance weighted,9,1.01 [0.79-1.3],0.907101357144288,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,6,0.99 [0.82-1.19],0.907498331630362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,REG1A,Lithostathine-1-alpha,Inverse variance weighted,8,1.01 [0.85-1.21],0.907655907410545,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,0.97 [0.55-1.69],0.909409776348576,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,12,0.99 [0.89-1.11],0.912603626892019,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MSMB,Beta-microseminoprotein,Inverse variance weighted,31,1 [0.91-1.08],0.914658082132393,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ALCAM,CD166 antigen,Inverse variance weighted,4,0.98 [0.62-1.53],0.916625025417964,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NPY,Pro-neuropeptide Y,Wald ratio,1,1.07 [0.29-3.98],0.920275020639095,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CLSTN2,Calsyntenin-2,Inverse variance weighted,15,1.01 [0.89-1.13],0.920702250409842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CXCL8,Interleukin-8,Inverse variance weighted,4,0.97 [0.57-1.67],0.921658332182982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PLXNB2,Plexin-B2,Inverse variance weighted,13,1 [0.92-1.08],0.922843170311804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CSPG4,Chondroitin sulfate proteoglycan 4,Wald ratio,1,1.02 [0.64-1.64],0.923248611346247,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,2,1.01 [0.77-1.34],0.928310106817235,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,5,1.01 [0.84-1.21],0.9349721183232,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,8,0.99 [0.84-1.17],0.935188657050644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LYPD3,Ly6/PLAUR domain-containing protein 3,Inverse variance weighted,10,0.99 [0.87-1.14],0.937048610726533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,WFDC2,WAP four-disulfide core domain protein 2,Wald ratio,1,0.97 [0.47-2.01],0.938803907024897,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,Inverse variance weighted,6,1.01 [0.73-1.41],0.944938822574528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,MB,Myoglobin,Wald ratio,1,0.95 [0.21-4.25],0.945129262008002,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DPT,Dermatopontin,Inverse variance weighted,16,0.99 [0.86-1.15],0.946524680272164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,Inverse variance weighted,3,1.02 [0.58-1.81],0.947089180941698,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,ACY1,Aminoacylase-1,Wald ratio,1,0.98 [0.62-1.57],0.947363706201748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.03 [0.4-2.69],0.948971763781495,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,HMCN2,Hemicentin-2,Inverse variance weighted,14,1 [0.91-1.1],0.950626747707358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DKK4,Dickkopf-related protein 4,Inverse variance weighted,3,0.99 [0.77-1.28],0.953717433944383,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.01 [0.76-1.34],0.954016455871152,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CTHRC1,Collagen triple helix repeat-containing protein 1,Wald ratio,1,0.96 [0.22-4.22],0.954866693956099,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,10,1 [0.9-1.12],0.956320200790845,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,5,1 [0.88-1.15],0.95643838012943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,4,0.99 [0.8-1.24],0.961926610253958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,3,0.99 [0.76-1.29],0.964774931394406,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD70,CD70 antigen,Inverse variance weighted,13,1 [0.9-1.11],0.965308127146463,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL17C,Interleukin-17C,Inverse variance weighted,3,0.99 [0.66-1.48],0.965722137785483,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,0.99 [0.6-1.62],0.967323923377735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,4,0.99 [0.61-1.61],0.969186921759481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CCL21,C-C motif chemokine 21,Inverse variance weighted,2,0.99 [0.59-1.68],0.974024463200758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,DLL1,Delta-like protein 1,Inverse variance weighted,3,0.99 [0.72-1.38],0.97459434887876,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,9,1 [0.77-1.28],0.976763397989824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CHGB,Secretogranin-1,Inverse variance weighted,16,1 [0.84-1.18],0.978369184302277,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,7,1 [0.75-1.35],0.978535030088071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,3,1 [0.79-1.28],0.979615307196245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,RGMA,Repulsive guidance molecule A,Inverse variance weighted,6,1 [0.74-1.35],0.981173849515905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,OMD,Osteomodulin,Wald ratio,1,0.99 [0.32-3.03],0.98189595171221,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,7,1 [0.77-1.3],0.98378910894455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1 [0.72-1.39],0.987355365176626,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,5,1 [0.84-1.18],0.987704465554133,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,INHBB,Inhibin beta B chain,Inverse variance weighted,6,1 [0.87-1.16],0.988679755545929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PI3,Elafin,Inverse variance weighted,7,1 [0.87-1.15],0.989965429348293,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,13,1 [0.89-1.12],0.99050516361776,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,NCS1,Neuronal calcium sensor 1,Wald ratio,1,1 [0.63-1.59],0.992512453147418,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.99 [0.25-3.89],0.993566125636268,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1 [0.65-1.53],0.994703886737907,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,4,1 [0.76-1.32],0.995663919346199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CDH17,Cadherin-17,Inverse variance weighted,7,1 [0.79-1.26],0.99625795646591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,1 [0.67-1.49],0.996780339993082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,10,1 [0.9-1.11],0.997084607415929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,8,1 [0.85-1.18],0.997699341060271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,12,1 [0.9-1.11],0.999877947154519,cis
